Developed by researchers from the Bar-Ilan University of Tel Aviv, this technology was presented at a conference at the Shaarei Hesed Medical Center by the European Society of Cataracts and Refractive Surgery.

The first tests have already been successfully performed on pigs eyes, which are structurally very similar to human eyes. It is expected that tests will soon be carried out on people who wish to participate in the study.

The technology consists of correcting certain natural errors in the shape of the eye that prevent the correct refraction of light and result in conditions such as nearsightedness, farsightedness, astigmatism or presbyopia.

In order to achieve correction, the process would consist of patients measuring their eyesight with the use of an electronic application, which already exists. Subsequently using a second application that is being developed, that sends pulses to the eye can mark which are the spaces of the cornea that must be corrected.

Finally, drops are placed with nanoparticles of proteins to correct the patient’s vision. Unlike the current options, this is not so invasive, as it does not remove tissue from the eye.

It may take some time before we see this in the medical market because of the gravity and sensitivity of the matter.